Indication
Cutaneous Merkel Cell Carcinoma
2 clinical trials
5 drugs
Clinical trial
A Randomized Phase II Study of Anti-PD1 Antibody [MK-3475 (Pembrolizumab)] Alone Versus Anti-PD1 Antibody Plus Stereotactic Body Radiation Therapy in Advanced Merkel Cell CarcinomaStatus: Active (not recruiting), Estimated PCD: 2022-06-07
Drug
mFOLFOX6Clinical trial
Immune Checkpoint Blockade for Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersStatus: Active (not recruiting), Estimated PCD: 2022-10-11
Drug
LurbinectedinDrug
T-VECDrug
R-CHOPDrug
Varlilumab